Miliary tuberculosis after initiation of ibrutinib in chronic lymphocytic leukemia

Ann Hematol. 2015 Aug;94(8):1419-20. doi: 10.1007/s00277-015-2385-0. Epub 2015 Apr 24.

Authors

Song-Yau Wang¹, Thomas Ebert, Nadja Jaekel, Stefan Schubert, Dietger Niederwieser, Haifa Kathrin Al-Ali

Affiliation

¹ Division of Hematology and Oncology, University Hospital of Leipzig, 04103, Leipzig, Germany.

PMID: 25903044
DOI: 10.1007/s00277-015-2385-0

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenine / analogs & derivatives
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis*
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
Male
Middle Aged
Piperidines
Pyrazoles / adverse effects*
Pyrimidines / adverse effects*
Tuberculosis, Miliary / chemically induced*
Tuberculosis, Miliary / diagnosis*

Substances

Piperidines
Pyrazoles
Pyrimidines
ibrutinib
Adenine